Activated HLA-DR+CD38+ Effector Th1/17 Cells Distinguish Crohn's Disease-associated Perianal Fistulas from Cryptoglandular Fistulas.

Autor: Ouboter LF; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands., Lindelauf C; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands., Jiang Q; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands., Schreurs M; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands., Abdelaal TR; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.; Bioinformatics Lab, Delft University of Technology, Delft, the Netherlands.; Systems and Biomedical Engineering Department, Faculty of Engineering Cairo University, Giza, Egypt., Luk SJ; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Barnhoorn MC; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands., Hueting WE; Department of Surgery, Alrijne hospital, Leiderdorp, the Netherlands., Han-Geurts IJ; Department of Surgery, Proctos Clinic, Bilthoven, the Netherlands., Peeters KCMJ; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Holman FA; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Koning F; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands., van der Meulen-de Jong AE; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands., Pascutti MF; Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands.

Publikováno v: Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Nov 04; Vol. 30 (11), pp. 2146-2161.

Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study.

Autor: van Lingen E; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands., Nooij S; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands., Terveer EM; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands., Crossette E; Vedanta Biosciences, Cambridge, MA, USA., Prince AL; Vedanta Biosciences, Cambridge, MA, USA., Bhattarai SK; University of Massachusetts Chan Medical School, Department of Microbiology and Physiological Systems, Worcester, MA, USA., Watson A; Vedanta Biosciences, Cambridge, MA, USA., Galazzo G; Vedanta Biosciences, Cambridge, MA, USA., Menon R; Vedanta Biosciences, Cambridge, MA, USA., Szabady RL; Vedanta Biosciences, Cambridge, MA, USA.; Ferring Pharmaceuticals, San Diego, CA, USA., Bucci V; University of Massachusetts Chan Medical School, Department of Microbiology and Physiological Systems, Worcester, MA, USA., Norman JM; Vedanta Biosciences, Cambridge, MA, USA., van der Woude CJ; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands., van der Marel S; Department of Gastroenterology and Hepatology, Haaglanden Medisch Centrum, den Haag, The Netherlands., Verspaget HW; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands., van der Meulen-de Jong AE; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands., Keller JJ; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Gastroenterology and Hepatology, Haaglanden Medisch Centrum, den Haag, The Netherlands.

Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Sep 03; Vol. 18 (9), pp. 1381-1393.

A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.

Autor: van Linschoten RCA; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands.; Department of Gastroenterology and Hepatology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Jansen FM; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands., Pauwels RWM; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands., Smits LJT; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands., Atsma F; Scientific Center for Quality of Healthcare, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Kievit W; Department for Health Evidence, Radboud University Medical Center, Radboud Institute for Health Science, Nijmegen, The Netherlands., de Jong DJ; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands., de Vries AC; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands., Boekema PJ; Department of Gastroenterology and Hepatology, Maxima Medical Center, Eindhoven, The Netherlands., West RL; Department of Gastroenterology and Hepatology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Bodelier AGL; Department of Gastroenterology and Hepatology, Amphia Hospital, Breda, The Netherlands., Gisbertz IAM; Department of Gastroenterology and Hepatology, Bernhoven Hospital, Uden, The Netherlands., Wolfhagen FHJ; Department of Gastroenterology and Hepatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Römkens TEH; Department of Gastroenterology and Hepatology, Jeroen Bosch Hospital, 'S-Hertogenbosch, The Netherlands., Lutgens MWMD; Department of Gastroenterology and Hepatology, Elisabeth Twee Steden Ziekenhuis, Tilburg, The Netherlands., van Bodegraven AA; Department of Gastroenterology, Geriatrics, Internal and Intensive Care Medicine (Co-MIK), Zuyderland Medical Center, Sittard-Geleen/Heerlen, The Netherlands., Oldenburg B; Department of Gastroenterology and Hepatology, UMC Utrecht, Utrecht, The Netherlands., Pierik MJ; Department of Gastroenterology and Hepatology, Maastricht University Medical Center +, Maastricht, The Netherlands., Russel MGVM; Department of Gastroenterology and Hepatology, Medisch Spectrum Twente, Twente, The Netherlands., de Boer NK; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Mallant-Hent RC; Department of Gastroenterology and Hepatology, Flevoziekenhuis, Almere, The Netherlands., Ter Borg PCJ; Department of Gastroenterology and Hepatology, Ikazia Hospital, Rotterdam, The Netherlands., van der Meulen-de Jong AE; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands., Jansen JM; Department of Gastroenterology and Hepatology, OLVG, Amsterdam, The Netherlands., Jansen SV; Department of Gastroenterology and Hepatology, Reinier de Graaf Gasthuis, Delft, The Netherlands., Tan ACITL; Department of Gastroenterology and Hepatology, CWZ Hospital, Nijmegen, The Netherlands., van der Woude CJ; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands., Hoentjen F; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands. hoentjen@ualberta.ca.; Division of Gastroenterology, Department of Medicine, University of Alberta, 2-20A Zeidler Ledcor Centre, 8540-112 Street NW, Edmonton, AB, T6G 2P8, Canada. hoentjen@ualberta.ca.

Publikováno v: Digestive diseases and sciences [Dig Dis Sci] 2024 Jun; Vol. 69 (6), pp. 2165-2174. Date of Electronic Publication: 2024 Apr 09.

Patient preferences in treatment options of ulcerative colitis: a discrete choice experiment.

Autor: Straatmijer T; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.; Amsterdam UMC, University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam, The Netherlands., van den Akker-van Marle ME; Department of Biomedical Data Sciences, section Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands., Ponsioen CY; Amsterdam UMC, University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam, The Netherlands., van der Horst D; Crohn & Colitis NL, Woerden, The Netherlands., Scherpenzeel MP; Crohn & Colitis NL, Woerden, The Netherlands., Duijvestein M; Radboudumc, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands., van der Meulen-de Jong AE; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, The Netherlands.

Publikováno v: Scandinavian journal of gastroenterology [Scand J Gastroenterol] 2024 Mar; Vol. 59 (3), pp. 288-295. Date of Electronic Publication: 2023 Dec 02.

Predicting response to iron supplementation in patients with active inflammatory bowel disease (PRIme): a randomised trial protocol.

Autor: Loveikyte R; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands r.loveikyte@lumc.nl.; Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands., Duijvestein M; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands., Mujagic Z; Department of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands., Goetgebuer RL; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Dijkstra G; Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands., van der Meulen-de Jong AE; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: BMJ open [BMJ Open] 2024 Jan 30; Vol. 14 (1), pp. e077511. Date of Electronic Publication: 2024 Jan 30.